Abstract
Blood-sucking leeches have been used for medical purposes in humans for hundreds of years. Accordingly, one of the most prominent species has been named Hirudo medicinalis by Carl Linne in 1758. Feeding on vertebrate blood poses some serious problems to blood-sucking ectoparasites, as they have to penetrate the body surface of the host and to suppress the normal reactions of the host to such injuries (swelling, pain, inflammation) to remain undetected during the feeding period. Furthermore, the parasites have to take measures to inhibit the normal reactions in host tissues to blood vessel damage, namely hemostasis and blood coagulation (platelet aggregation and activation, activation of thrombin and formation of fibrin clots). During evolution, leeches have acquired the ability to control these processes in their hosts by transferring various bioactive substances to the host. These substances are supposedly produced in unicellular salivary gland cells and injected into the wound at the feeding site through tiny salivary ductule openings in the jaws that the leech uses to slice open the host body surface and to cut blood vessels in the depth of the wound. This review summarizes current knowledge about the salivary gland cells and the biological effects of individual saliva components as well as hints to the potential usefulness of some of these compounds for medical purposes.
Similar content being viewed by others
References
Adams GL, Manson RJ, Turner I, Sindram D, Lawson JH (2007) The balance of thrombosis and hemorrhage in surgery. Hematol Oncol Clin North Am 21:13–24
Ascenzi P, Aducci P, Amiconi G, Ballio A, Guaragna A, Menegatti E, Schnebli HP, Bolognesi M (1991) Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study. J Mol Recognit 4:113–119
Ascenzi P, Amiconi G, Bode W, Bolognesi M, Coletta M, Menegatti E (1995) Proteinase inhibitors from the European medicinal leech Hirudo medicinalis: structural, functional and biomedical aspects. Mol Aspects Med 16:215–313
Ascenzi P, Amiconi G, Coletta M, Lupidi G, Menegatti E, Onesti S, Bolognesi M (1992) Binding of hirudin to human alpha, beta and gamma-thrombin. A comparative kinetic and thermodynamic study. J Mol Biol 225:177–184
Bajzar L, Manuel R, Nesheim ME (1995) Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 270:14477–14484
Barnes CS, Krafft B, Frech M, Hofmann UR, Papendieck A, Dahlems U, Gellissen G, Hoylaerts MF (2001) Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagen. Semin Thromb Hemost 27:337–348
Baskova IP, Ferner Z, Balkina AS, Kozin S, Kharitonova OV, Zavalova LL, Zgoda VG (2008a) Steroids, histamine and serotonin in medicinal leech salivary gland secretions. Biomed Khim 54:127–139
Baskova IP, Kostrjukova ES, Vlasova MA, Kharitonova OV, Levitskiy SA, Zavalova LL, Moshkovskii SA, Lazarev VN (2008b) Proteins and peptides of the salivary gland secretion of medicinal leeches Hirudo verbana, H. medicinalis, and H. orientalis. Biochemistry (Mosc) 73:315–320
Baskova IP, Nikonov GI (1991) Destabilase, the novel epsilon-(gamma-Glu)-Lys isopeptidase with thrombolytic activity. Blood Coagul Fibrinolysis 2:167–172
Baskova IP, Zavalova LL (2001) Proteinase inhibitors from the medicinal leech Hirudo medicinalis. Biochemistry (Mosc) 66:703–714
Baskova I, Zavalova L (2008) Polyfunctionality of lysozyme destabilase from the medicinal leech. Russ J Bioorg Chem 34:304–309
Baskova IP, Zavalova LL, Basanova AV, Moshkovskii SA, Zgoda VG (2004) Protein profiling of the medicinal leech salivary gland secretion by proteomic analytical methods. Biochemistry (Mosc) 69:770–775
Baskova IP, Zavalova LL, Basanova AV, Sass AV (2001) Separation of monomerizing and lysozyme activities of destabilase from medicinal leech salivary gland secretion. Biochemistry (Mosc) 66:1368–1373
Berg T, Carretero OA, Scicli AG, Tilley B, Stewart JM (1989) Role of kinin in regulation of rat submandibular gland blood flow. Hypertension 14:73–80
Bergmann C, Dodt J, Kohler S, Fink E, Gassen HG (1986) Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis. Biol Chem Hoppe Seyler 367:731–740
Bodong A (1905) Über Hirudin. Arch Exp Pathol Pharmacol 52:242–261
Boffa MB, Reid TS, Joo E, Nesheim ME, Koschinsky ML (1999) Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). Biochemistry 38:6547–6558
Braun NJ, Schnebli HP (1987) Interaction of eglin c with polymorphonuclear cells: evidence for binding to the cell surface. Biol Chem Hoppe Seyler 368:155–161
Braun NJ, Bodmer JL, Virca GD, Metz-Virca G, Maschler R, Bieth JG, Schnebli HP (1987) Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G. Biol Chem Hoppe Seyler 368:299–308
Chalisova NI, Pennijajnen VP, Baskova IP, Zavalova LL, Bazanova AV (2003) The neurite-stimulating activity of components of the salivary gland secretion of the medicinal leech in cultures of sensory neurons. Neurosci Behav Physiol 33:411–414
Cicardi M, Zingale L, Zanichelli A, Pappalardo E, Cicardi B (2005) C1 inhibitor: molecular and clinical aspects. Springer Sem Immunopathol 27:286–298
Cruz CP, Eidt J, Drouilhet J, Brown AT, Wang Y, Barnes CS, Moursi MM (2001) Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg 34:724–729
Damas D (1972) Durcissement de la cuticule des machoires chez Hirudo medicinalis (Annelide, Hirudinee). Aboutissant aux structures dentaires etude histochemique et ultrastructurale. Arch Zool Exp Gen 113:401–421
Damas D (1974) Etude histologique et histochemique des glandes salivaires de la sangsue medicinale, Hirudo medicinalis (Hirudinee, Gnathobdelle). Arch Zool Exp Gen 115:279–292
Deckmyn H, Stassen JM, Vreys I, Van Houtte E, Sawyer RT, Vermylen J (1995) Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters. Blood 85:712–719
Domogalla B (2005) NMR-Lösungsstruktur des Proteins Saratin, strukturelle Charakterisierung der Saratin-Kollagen-Interaktion und des Carausius morosus-hyperthrehalosämischen Hormons (Cam-HrTH-I). Dissertation, University of Regensburg
Electricwala A, Hartwell R, Scawen MD, Atkinson T (1993) The complete amino acid sequence of a hirudin variant from the leech Hirudinaria manillensis. J Protein Chem 12:365–370
Elliott EJ (1986) Chemosensory stimuli in feeding behavior of the leech Hirudo medicinalis. J Comp Physiol A 159:391–401
Elliott JM (2008) Population size, weight distribution and food in a persistent population of the rare medicinal leech, Hirudo medicinalis. Freshwater Biology 53:1502–1512
Fenton JW (1986) Thrombin. Ann N Y Acad Sci 485:5–15
Fink E, Rehm H, Gippner C, Bode W, Eulitz M, Machleidt W, Fritz H (1986) The primary structure of bdellin B-3 from the leech Hirudo medicinalis. Bdellin B-3 is a compact proteinase inhibitor of a “non-classical” Kazal type. It is present in the leech in a high molecular mass form. Biol Chem Hoppe Seyler 367:1235–1242
Fradkov A, Berezhnoy S, Barsova E, Zavalova L, Lukyanov S, Baskova I, Sverdlov ED (1996) Enzyme from the medicinal leech (Hirudo medicinalis) that specifically splits endo-[epsilon](-[gamma]-Glu)-Lys isopeptide bonds: cDNA cloning and protein primary structure. FEBS Lett 390:145–148
Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27–33
Furie B, Furie BC (2008) Mechanisms of thrombus formation. N Engl J Med 359:938–949
Graf J, Kikuchi Y, Rio RVM (2006) Leeches and their microbiota: naturally simple symbiosis models. Trends Microbiol 14:365–371
Gronwald W, Bomke J, Maurer T, Domogalla B, Huber F, Schumann F, Kremer W, Fink F, Rysiok T, Frech M, Kalbitzer HR (2008) Structure of the leech protein saratin and characterization of its binding to collagen. J Mol Biol 381:913–927
Hach W, Scholz S, Hach-Wunderle V (2005) Die Therapie mit Blutegeln in der Medizin und Gefäßmedizin. Gefäßchirurgie 10:195–202
Harbrecht U (2011) Old and new anticoagulants. Hämostaseologie 31:21–27
Harsfalvi J, Stassen JM, Hoylaerts MF, Van Houtte E, Sawyer RT, Vermylen J, Deckmyn H (1995) Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions. Blood 85:705–711
Harvey RP, Degryse E, Stefani L, Schamber F, Cazenave JP, Courtney M, Tolstoshev P, Lecocq JP (1986) Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis. Proc Natl Acad Sci USA 83:1084–1088
Haycraft JB (1884) On the action of a secretion obtained from the medicinal leech on the coagulation of the blood. Proc R Soc Lond B 36:478–487
Hirsh J (1991) Heparin. N Engl J Med 324:1565–1574
Hornebeck W, Soleilhac JM, Tixier JM, Moczar E, Robert L (1987) Inhibition by elastase inhibitors of the formyl Met Leu Phe-induced chemotaxis of rat polymorphonuclear leukocytes. Cell Biochem Funct 5:113–122
Hovingh P, Linker A (1999) Hyaluronidase activity in leeches (Hirudinea). Comp Biochem Physiol B Biochem Mol Biol 124:319–326
Jensen KB, Rinvik SF, Venneroed AM (1965) Experiments on the in vitro inactivation of plasma kinins by carboxypeptidase B, plasma kininase or erythrocyte kininase in the presence of disulfiram. Acta Pharmacol Toxicol (Copenh) 22:187–195
Johnson PH (1994) Hirudin: clinical potential of a thrombin inhibitor. Annu Rev Med 45:165–177
Junger WG, Hallstrom S, Redl H, Schlag G (1992) Inhibition of human, ovine, and baboon neutrophil elastase with eglin c and secretory leukocyte proteinase inhibitor. Biol Chem Hoppe Seyler 373:119–122
Knobloch K, Gohritz A, Busch K, Spies M, Vogt PM (2007) Hirudo medicinalis-leech applications in plastic and reconstructive microsurgery—a literature review. Handchir Mikrochir Plast Chir 39:103–107
Lent CM, Fliegner KH, Freedman E, Dickinson MH (1988) Ingestive behaviour and physiology of the medicinal leech. J Exp Biol 137:513–527
Linker A, Meyer K, Hoffman P (1960) The production of hyaluronate oligosaccharides by leech hyaluronidase and alkali. J Biol Chem 235:924–927
Märki WE, Grossenbacher H, Grütter MG, Liersch MH, Meyhack B, Heim J (1991) Recombinant hirudin: genetic engineering and structure analysis. Semin Thromb Hemost 17:88–93
Major RH (1954) A history of medicine. Charles Thomas, Springfield, Illinois
Mann KH (1962) Leeches (Hirudinea). Pergamon, Oxford
Markwardt F (1955) Untersuchungen über hirudin. Naturwiss 42:537–538
Markwardt F, Nowak G, Stürzebecher J, Griessbach U, Walsmann P, Vogel G (1984) Pharmacokinetics and anticoagulant effect of hirudin in man. Thromb Haemost 52:160–163
Markwardt F, Nowak G, Stürzebecher J, Vogel G (1988) Clinico-pharmacological studies with recombinant hirudin. Thromb Res 52:393–400
Marshall I (1984) Characterization and distribution of histamine H1- and H2-receptors in precapillary vessels. J Cardiovasc Pharmacol 6(Suppl 4):S587–S597
Marshall CG, Lent CM (1988) Excitability and secretory activity in the salivary gland cells of jawed leeches (Hirudinea: Gnathobdellida). J Exp Biol 137:89–105
Michalsen A, Deuse U, Esch T, Dobos G, Moebus S (2001) Effect of leeches therapy (Hirudo medicinalis) in painful osteoarthritis of the knee: a pilot study. Ann Rheum Dis 60:986
Min GS, Sarkar IN, Siddall ME (2010) Salivary transcriptome of the North American medicinal leech, Macrobdella decora. J Parasitol 96:1211–1221
Mory RN, Mindell D, Bloom DA (2000) The leech and the physician: biology, etymology, and medical practice with Hirudinea medicinalis. World J Surg 24:878–883
Moser M, Auerswald E, Mentele R, Eckerskorn C, Fritz H, Fink E (1998) Bdellastasin, a serine protease inhibitor of the antistasin family from the medical leech (Hirudo medicinalis)—primary structure, expression in yeast, and characterisation of native and recombinant inhibitor. Eur J Biochem 253:212–220
Munro R, Hechtel FO, Sawyer RT (1989) Sustained bleeding after a leech bite in the apparent absence of hirudin. Thromb Haemost 61:366–369
Munro R, Jones CP, Sawyer RT (1991) Calin—a platelet adhesion inhibitor from the saliva of the medicinal leech. Blood Coagul Fibrinolysis 2:179–184
Nowak G, Schrör K (2007) Hirudin—the long and stony way from an anticoagulant peptide in the saliva of medicinal leech to a recombinant drug and beyond. A historical piece. Thromb Haemost 98:116–119
Olson ST, Shore JD (1982) Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 257:14891–14895
Oppler P (1904) Feinere Anatomie der im Kopf- und Halsteil von Hirudo vorkommenden Drüsen. Dissertation, University of Bern
Parent F, Bridey F, Dreyfus M, Musset D, Grimon G, Duroux P, Meyer D, Simonneau G (1993) Treatment of severe venous thrombo-embolism with intravenous hirudin (HBW 023): an open pilot study. Thromb Haemost 70:386–388
Payne V, Kam PC (2004) Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 59:695–703
Petrauskiene L, Utevska O, Utevsky S (2009) Can different species of medicinal leeches (Hirudo spp.) interbreed? Invertebrate Biology 128:324–331
Pettigrew HD, Teuber SS, Gershwin ME (2009) Clinical significance of complement deficiencies. Ann N Y Acad Sci 1173:108–123
Pilcher H (2004) Medicinal leeches: stuck on you. Nature 432:10–11
Qasim MA, Ganz PJ, Sauners CW, Bateman KS, James MN, Laskowski M (1997) Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases. Biochemistry 36:1598–1607
Rester U, Bode W, Moser M, Parry MA, Huber R, Auerswald E (1999) Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system. J Mol Biol 293:93–106
Reverter D, Vendrell J, Canals F, Horstmann J, Aviles FX, Fritz H, Sommerhoff CP (1998) A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization. J Biol Chem 273:32927–32933
Ribeiro JM, Makoul GT, Levine J, Robinson DR, Spielman A (1985) Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini. J Exp Med 161:332–344
Riede F, Koenen W, Goerdt S, Ehmke H, Faulhaber J (2010) Medicinal leeches for the treatment of venous congestion and hematoma after plastic reconstructive surgery. J Dtsch Dermatol Ges 8:881–888
Rigbi M, Levy H, Eldor A, Iraqi F, Teitelbaum M, Orevi M, Horovitz A, Galun R (1987a) The saliva of the medicinal leech Hirudo medicinalis—II. Inhibition of platelet aggregation and of leukocyte activity and examination of reputed anaesthetic effects. Comp Biochem Physiol C 88:95–98
Rigbi M, Levy H, Iraqi F, Teitelbaum M, Orevi M, Alajoutsijarvi A, Horovitz A, Galun R (1987b) The saliva of the medicinal leech Hirudo medicinalis—I. Biochemical characterization of the high molecular weight fraction. Comp Biochem Physiol B 87:567–573
Rigbi M, Orevi M, Eldor A (1996) Platelet aggregation and coagulation inhibitors in leech saliva and their roles in leech therapy. Semin Thromb Hemost 22:273–278
Rosenberg RD (1975) Actions and interactions of antithrombin and heparin. N Engl J Med 292:146–151
Roters F-J, Zebe E (1992) Protease inhibitors in the alimentary tract of the medicinal leech Hirudo medicinalis: In vivo and in vitro studies. J Comp Physiol B 162:85–92
Sadler JE (1998) Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67:395–424
Sakharov DV, Plow EF, Rijken DC (1997) On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem 272:14477–14482
Salzet M, Chopin V, Baert J-L, Matias I, Malecha J (2000) Theromin, a novel leech thrombin inhibitor. J Biol Chem 275:30774–30780
Sarma JV, Ward PA (2011) The complement system. Cell Tissue Res 343:227–235
Sawyer RT (1986a) Leech biology and behaviour 1: anatomy, physiology, and behaviour. Oxford University Press, Oxford
Sawyer RT (1986b) Leech biology and behaviour 2: feeding biology, ecology and systematics. Oxford University Press, Oxford
Seemüller U, Meier M, Ohlsson K, Müller HP, Fritz H (1977) Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches. Hoppe Seylers Z Physiol Chem 358:1105–1107
Seemüller U, Eulitz M, Fritz H, Strobl A (1980) Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis. Hoppe Seylers Z Physiol Chem 361:1841–1846
Siddall ME, Trontelj P, Utevsky SY, Nkamany M, Macdonald KS (2007) Diverse molecular data demonstrate that commercially available medicinal leeches are not Hirudo medicinalis. Proc R Soc B 274:1481–1487
Silver AC, Rabinowitz NM, Kuffer S, Graf J (2007) Identification of Aeromonas veronii genes required for colonization of the medicinal leech, Hirudo verbana. J Bacteriol 189:6763–6772
Skrzypczak-Jankun E, Carperos VE, Ravichandran KG, Tulinsky A, Westbrook M, Maraganore JM (1991) Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. J Mol Biol 221:1379–1393
Snider GL, Stone PJ, Lucey EC, Breuer R, Calore JD, Seshadri T, Catanese A, Maschler R, Schnebli HP (1985) Eglin-c, a polypeptide derived from the medicinal leech, prevents human neutrophil elastase-induced emphysema and bronchial secretory cell metaplasia in the hamster. Am Rev Respir Dis 132:1155–1161
Söllner C, Mentele R, Eckerskorn C, Fritz H, Sommerhoff CP (1994) Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis. Eur J Biochem 219:937–943
Sommerhoff CP, Söllner C, Mentele R, Piechottka GP, Auerswald EA, Fritz H (1994) A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. Biol Chem Hoppe Seyler 375:685–694
Steranka LR, Manning DC, De Haas CJ, Ferkany JW, Borosky SA, Connor JR, Vavrek RJ, Stewart JM, Snyder SH (1988) Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci USA 85:3245–3249
Stone SR, Hofsteenge J (1991) Recombinant hirudin: kinetic mechanism for the inhibition of human thrombin. Protein Eng 4:295–300
Stone SR, Tapparelli C (1995) Thrombin inhibitors as antithrombotic agents: the importance of rapid inhibition. J Enzyme Inhib 9:3–15
Stubbs MT, Morenweiser R, Stürzebecher J, Bauer M, Bode W, Huber R, Piechottka GP, Matschiner G, Sommerhoff CP, Fritz H, Auerswald EA (1997) The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition. J Biol Chem 272:19931–19937
Suter S, Chevallier I (1988) The effect of eglin C on the function of human neutrophils in vitro. Biol Chem Hoppe Seyler 369:573–578
Tuszynski GP, Gasic TB, Gasic GJ (1987) Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation. J Biol Chem 262:9718–9723
Utevsky S, Kovalenko N, Doroshenko K, Petrauskiene L, Klymenko V (2009) Chromosome numbers for three species of medicinal leeches (Hirudo spp.). Syst Parasitol 74:95–102
Vanderslice P, Ballinger SM, Tam EK, Goldstein SM, Craik CS, Caughey GH (1990) Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Nat Acad Sci USA 87:3811–3815
Vilahur G, Duran X, Juan-Babot O, Casani L, Badimon L (2004) Antithrombotic effects of saratin on human atherosclerotic plaques. Thromb Haemost 92:191–200
Wardlaw JM, Sandercock PA, Murray V (2009) Should more patients with acute ischaemic stroke receive thrombolytic treatment? BMJ 339:b4584
Weitz JI, Huboda M, Massel D, Maraganore J, Hirsh J (1990) Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 86:385–391
Wenning A (1996) Managing high salt loads: from neuron to urine in the leech. Physiol Zool 69:719–745
Wilkin PJ, Scofield AM (1991) Growth of the medicinal leech, Hirudo medicinalis, under natural and laboratory conditions. Freshwater Biol 25:547–553
Yanes O, Villanueva J, Querol E, Aviles FX (2005) Functional screening of serine protease inhibitors in the medical leech Hirudo medicinalis monitored by intensity fading MALDI-TOF MS. Mol Cell Proteomics 4:1602–1613
Yantis MA, O'Toole KN, Ring P (2009) Leech therapy. Am J Nurs 109:36–42
Yip J, Shen Y, Andrews RK (2004) Primary platelet adhesion receptors. Australian Biochemist 35:4–8
Yousef GM, Diamandis EP (2001) The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 22:184–204
Zavalova LL, Artamonova II, Berezhnoy SN, Tagaev AA, Baskova IP, Andersen J, Roepstorff P, Egorov TA (2003) Multiple forms of medicinal leech destabilase-lysozyme. Biochem Biophys Res Commun 306:318–323
Zavalova LL, Baskova IP, Lukyanov SA, Sass AV, Snezhkov EV, Akopov SB, Artamonova II, Archipova VS, Nesmeyanov VA, Kozlov DG, Benevolensky SV, Kiseleva VI, Poverenny AM, Sverdlov ED (2000) Destabilase from the medicinal leech is a representative of a novel family of lysozymes. Biochim Biophys Acta–Prot Struct Mol Enzymol 1478:69–77
Zavalova LL, Kuzina EV, Levina NB, Baskova IP (1993) Monomerization of fragment DD by destabilase from the medicinal leech does not alter the N-terminal sequence of the gamma-chain. Thromb Res 71:241–244
Zavalova LL, Yudina TG, Artamonova II, Baskova IP (2006) Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides. Chemotherapy 52:158–160
Zerbst-Boroffka I, Wenning A (1986) Mechanisms of regulatory salt and water excretion in the leech, Hirudo medicinalis L. Zool Beitr NF 30:359–377
Acknowledgements
Due to limitations in space, the authors were not able to cite every single piece of work of other researchers in the field and have focussed on the most influential publications. We apologize for every important contribution that we may have overlooked. The authors would like to thank Gabriele Uhl and Christine Putzar for their cooperation in the histological project and Steffen Harzsch and Verena Rieger for their help with the histamine immune fluorescence. Thanks to Detlef Menzel (BioRepro GmbH, Potsdam) for providing the animals. We are thankful to the four reviewers for their constructive and helpful comments. Sarah Lemke is the recipient of a doctoral stipend from the Konrad Adenauer-Stiftung, Germany.
Ethical standards
We declare that the experiments described in this paper comply with the current laws in Germany.
Conflicts of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Sven Thatje
Electronic supplementary material
Below is the link to the electronic supplementary material.
Hirudo verbana attaches itself to a piece of porcine intestine (wetted using PBS containing 0.75 mol/l arginine) and slices the tissue using its toothed jaws. (MPG 12184 kb)
Online Resource 2
Methodological details for the preparation of histological sections (5 μm thickness) of the paraffin-embedded anterior part (< segment 10) of a leech (Hirudo verbana) and for Azan staining of tissue sections. (PDF 13 kb)
Online Resource 3
Methodological details of histamine detection in the elongated portions of salivary gland cells by immune fluorescence in longitudinal cryosections (5 μm thickness) of the anterior segments (<10) of Hirudo verbana. (PDF 12 kb)
Rights and permissions
About this article
Cite this article
Hildebrandt, JP., Lemke, S. Small bite, large impact–saliva and salivary molecules in the medicinal leech, Hirudo medicinalis . Naturwissenschaften 98, 995–1008 (2011). https://doi.org/10.1007/s00114-011-0859-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00114-011-0859-z